macular degeneration
Information
- Disease name
- macular degeneration
- Disease ID
- DOID:4448
- Description
- "A retinal degeneration characterized by gradual deterioration of light-sensing cells in the tissues at the back of the eye and has_symptom vision loss." [url:http\://ghr.nlm.nih.gov/condition/age-related-macular-degeneration, url:http\://rarediseases.info.nih.gov/gard/10260/macular-degeneration/resources/1]
Disease area statistics
Chromosome band
| Gene symbol | Chromosome | Start | Stop | The number of variant |
|---|---|---|---|---|
| TTPA | 8 | 63,059,488 | 63,086,053 | 4 |
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03815825 | Active, not recruiting | Phase 2 | GOLDEN STUDY: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD) | March 4, 2019 | June 2024 |
| NCT03894020 | Active, not recruiting | GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD) | January 8, 2019 | March 2, 2024 | |
| NCT03846193 | Active, not recruiting | Phase 1/Phase 2 | FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD | December 17, 2018 | June 28, 2024 |
| NCT04270604 | Active, not recruiting | Biological Sample Collection for Research and Biobanking | February 6, 2012 | January 2030 | |
| NCT00001346 | Completed | Diabetic Retinopathy and Visual Function Study | November 1992 | October 2000 | |
| NCT00001395 | Completed | Long Term Follow-Up of Diabetic Retinopathy | March 1994 | August 2000 | |
| NCT00001615 | Completed | Phase 1 | Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration | July 1997 | May 2000 |
| NCT00001733 | Completed | Screening for Studies on Retinovascular Diseases | March 6, 1998 | July 2, 2008 | |
| NCT00006202 | Completed | Phase 2 | Lutein for Age-Related Macular Degeneration | September 2000 | August 2003 |
| NCT00008515 | Completed | Phase 1 | Fluocinolone Implant to Treat Macular Degeneration | January 2001 | December 2001 |
| NCT00018070 | Completed | Phase 1 | Identification and Treatment of Feeder Vessels in Macular Degeneration | June 28, 2001 | August 30, 2006 |
| NCT00021736 | Completed | Phase 2/Phase 3 | Phase II/III Study of Anti-VEGF in Neovascular AMD | July 2001 | July 2002 |
| NCT00041444 | Completed | Multi-Ethnic Study of Atherosclerosis (MESA) - Ancillary Eye Study | June 2002 | November 2006 | |
| NCT00041483 | Completed | Phase 3 | Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMD | June 2002 | August 2005 |
| NCT00042211 | Completed | Phase 3 | Preventing Depression in Patients With Macular Degeneration | February 2001 | January 2006 |
| NCT00043680 | Completed | Phase 2 | Celecoxib to Treat Macular Degeneration in Patients Receiving Photodynamic Therapy | August 2002 | January 2005 |
| NCT00050479 | Completed | Phase 3 | Laser and Medical Treatment of Diabetic Macular Edema | December 2002 | July 2006 |
| NCT00051129 | Completed | Phase 3 | Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD) | January 2007 | May 2008 |
| NCT00056836 | Completed | Phase 3 | A Study to Evaluate rhuFab V2 in Subjects With Minimally Classic or Occult Subfoveal Neovascular Macular Degeneration | March 2003 | December 2005 |
| NCT00414999 | Completed | Phase 1 | A Phase 1 Safety Study of TG100801 Eye Drops in Healthy Volunteers | November 2006 | February 2007 |
| NCT00000150 | Completed | Phase 3 | Submacular Surgery Trials (SST) | January 1999 | September 2001 |
| NCT00000162 | Completed | Phase 3 | Branch Vein Occlusion Study | July 1977 | |
| NCT00000167 | Completed | Phase 3 | Complications of Age-Related Macular Degeneration Prevention Trial | May 1999 | June 2006 |
| NCT00570193 | Completed | Phase 1/Phase 2 | Photodynamic and Pharmacologic Treatment of CNV | December 2006 | June 2011 |
| NCT00605943 | Completed | Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab or Ranibizumab | January 16, 2008 | August 4, 2009 | |
| NCT00612456 | Completed | Phase 2 | To Evaluate the Pharmacodynamics, Safety, and Pharmacokinetics of Pazopanib Drops in Adult Subjects With Neovascular AMD | March 5, 2008 | June 17, 2009 |
| NCT00637377 | Completed | Phase 3 | Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD) | April 2008 | August 2011 |
| NCT00656903 | Completed | High Speed Indocyanine Green Angiography Findings in Ranibizumab Treatment for Wet Age-related Macular Degeneration | April 7, 2008 | August 19, 2014 | |
| NCT00658619 | Completed | Phase 2 | Safety and Efficacy of Brimonidine Intravitreal Implant in Patients With Geographic Atrophy Due to Age-related Macular Degeneration (AMD) | May 1, 2008 | April 8, 2011 |
| NCT00659555 | Completed | Phase 1 | Study Of The Repeat Dosing Of Ketoconazole On The Pharmacokinetics Of A Single Dose Of Pazopanib (GW786034) Eye Drops | April 4, 2008 | May 10, 2008 |
| NCT00668213 | Completed | Antioxidant Systems and Age-Related Macular Degeneration | June 2006 | June 2010 | |
| NCT00708929 | Completed | N/A | Does Complement Factor H Gene Polymorphism Play a Role in the Regulation of Vascular Tone in the Choroid? | June 2009 | December 2011 |
| NCT00709449 | Completed | Phase 2/Phase 3 | An Open Study Comparing the Effects of Moxaverine on Ocular Blood Flow in Patients With Age- Related Macular Degeneration, Primary Open Angle Glaucoma and Healthy Control Subjects | May 2008 | March 2009 |
| NCT00722384 | Completed | Phase 1 | Open Label Study for the Evaluation of Tolerability of Five Dose Levels of Cand5 | August 2004 | December 2007 |
| NCT00727753 | Completed | VEGF-antagonism and Endothelial Function in Age-related Macular Degeneration (AMD) | July 2008 | October 2013 | |
| NCT00733304 | Completed | Phase 2 | An Extension to Study MD7108240 | June 25, 2008 | September 9, 2009 |
| NCT00769392 | Completed | N/A | Pilot Study: A Randomized Trial Of Anesthetic Agents For Intravitreal Injection | September 2008 | August 12, 2009 |
| NCT00784225 | Completed | Phase 3 | S0000B: Vitamin E and/or Selenium in Preventing Cataract and Age-Related Macular Degeneration in Men on SELECT SWOG-S0000 | July 2004 | May 2018 |
| NCT00804921 | Completed | Phase 2 | Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis in Intraocular Pressure (IOP) After Bevacizumab | ||
| NCT00845273 | Completed | Long-Term Use Of Pegaptanib In Patients For Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration | November 2008 | February 2014 | |
| NCT00877032 | Completed | Phase 1 | Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration | April 2009 | July 2011 |
| NCT00896779 | Completed | Phase 2 | Lucentis in Advanced Macular Degeneration | October 2009 | September 2013 |
| NCT00976235 | Completed | N/A | A Long-Term Monitoring Study of the IMT-002 Patients | June 2006 | May 2011 |
| NCT01003691 | Completed | Phase 1 | Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy | August 5, 2010 | April 19, 2013 |
| NCT01006538 | Completed | Phase 4 | Macular EpiRetinal Brachytherapy Versus Lucentis® Only Treatment (MERLOT) | November 2009 | December 2016 |
| NCT01016873 | Completed | Phase 2 | INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD | November 2009 | April 2014 |
| NCT01024998 | Completed | Phase 1 | Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD) | January 11, 2010 | July 2018 |
| NCT01051700 | Completed | Phase 1 | A Safety Study in Healthy Volunteers to Evaluate Safety, How Fast the Drug is Absorbed, and the Side Effects of the Drug in Humans | January 12, 2010 | May 27, 2010 |
| NCT01072214 | Completed | Phase 1 | A Safety Study to Evaluate Pazopanib Eye Drops in Healthy Volunteers | March 9, 2010 | June 28, 2010 |
| NCT01115231 | Completed | Complement Factor H Haplotypes and Smoking in Age-related Macular Degeneration | October 2010 | December 31, 2016 | |
| NCT01134055 | Completed | Phase 2 | Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration | June 1, 2010 | October 1, 2012 |
| NCT01154062 | Completed | Phase 1 | A Study to Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular Degeneration | August 16, 2010 | April 29, 2011 |
| NCT01204541 | Completed | A Single-Center Pilot Study to Assess Macular Function | September 2010 | October 2010 | |
| NCT01245387 | Completed | Observational Study Of The Long-Term Effect Of Macugen In Patients With Wet Age-Related Macular Degeneration | August 2006 | December 2009 | |
| NCT01482910 | Completed | Phase 3 | VEGF Trap-Eye: Investigation of Efficacy and Safety in Chinese Subjects With Wet AMD (Age-Related Macular Degeneration) | December 2011 | August 2014 |
| NCT01494805 | Completed | Phase 1/Phase 2 | Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration | December 2011 | August 2017 |
| NCT01600300 | Completed | Phase 1/Phase 2 | Efficacy of Electrical Micro-current Retinal Stimulation for Treatment of Dry Age-related Macular Degeneration | August 2002 | April 2004 |
| NCT01632527 | Completed | Phase 1/Phase 2 | Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD) | June 2012 | June 2015 |
| NCT01653184 | Completed | N/A | Effect of Omega-3-fatty Acids on Blood Levels Omega-3 Fatty Acids in Patients With Age-related Macular Degeneration | July 2012 | March 2014 |
| NCT01670643 | Completed | Reading Performance With a Video Magnifier | January 2010 | February 2011 | |
| NCT01748292 | Completed | Phase 3 | Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab | December 2012 | February 2017 |
| NCT01749891 | Completed | Phase 1/Phase 2 | A Safety And Efficacy Study Of ALG-1001 In Human Subjects With Wet Age-Related Macular Degeneration | March 2012 | June 7, 2013 |
| NCT01756248 | Completed | EYLEA Age-Related Macular Degeneration (AMD) Post-marketing Surveillance in Japan | December 26, 2012 | May 20, 2019 | |
| NCT01756261 | Completed | EYLEA [AMD-QOL(Age-Related Macular Degeneration-Quality of Life)] Post-marketing Surveillance in Japan | December 26, 2012 | February 27, 2017 | |
| NCT01771081 | Completed | Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF Therapy | April 2013 | April 2015 | |
| NCT01773954 | Completed | N/A | Repeated Eye Injections of Aflibercept for Treatment of Wet Age Related Macular Degeneration | February 2013 | March 2016 |
| NCT01783925 | Completed | Eylea Post Marketing Surveillance(PMS) | April 29, 2014 | December 31, 2018 | |
| NCT01831947 | Completed | Phase 4 | Efficacy Study of Ranibizumab on Patients With Age-related Macular Degeneration. | April 2010 | March 2013 |
| NCT01933152 | Completed | Study to Assess the EffectiVeness of exIsting Anti-vascular Endothelial groWth Factor (Anti-VEGF) Treatment Regimens in Patients With Wet Age-related Macular Degeneration | August 2012 | April 2013 | |
| NCT01941082 | Completed | Phase 1 | A Study of RO6867461 Administered in Single- and Multiple-Ascending Doses in Patients With Wet Age-Related Macular Degeneration | December 2013 | February 2015 |
| NCT02090751 | Completed | Development of a Device to Measure Dark Adaptation | July 2014 | April 2015 | |
| NCT02157077 | Completed | Phase 3 | Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration | December 2013 | December 2015 |
| NCT02181504 | Completed | Phase 2 | A Study of Abicipar Pegol in Japanese Patients With Neovascular Age-related Macular Degeneration | September 2014 | December 2015 |
| NCT02181517 | Completed | Phase 2 | A Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration | July 2014 | March 2015 |
| NCT02225119 | Completed | The Focal Electro-Oculogram in Macular Disease | February 6, 2015 | February 28, 2020 | |
| NCT02264938 | Completed | N/A | Drusen Morphology Changes in Nonexudative Age-related Degeneration After Oral Antioxidants Supplementation | January 2013 | October 2014 |
| NCT02313259 | Completed | The Impact of Ocular Diseases on Driving: a Prospective Study | February 2012 | February 23, 2015 | |
| NCT02332941 | Completed | Phase 1 | Treatment -Resistant Neovascular Age-Related Macular Degeneration | August 2014 | June 2015 |
| NCT02390245 | Completed | N/A | Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study | September 2014 | August 2020 |
| NCT02420132 | Completed | Study to Evaluate Home Vision Testing in Participants Who Receive Ranibizumab (Lucentis®) | April 20, 2015 | August 25, 2016 | |
| NCT02452840 | Completed | Photodynamic Therapy for PDA in NV AMD | May 11, 2015 | August 2019 | |
| NCT02462486 | Completed | Phase 3 | Safety and Efficacy of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration | June 25, 2015 | June 6, 2019 |
| NCT02462928 | Completed | Phase 3 | A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration | June 25, 2015 | June 19, 2019 |
| NCT02510794 | Completed | Phase 2 | Study of the Efficacy and Safety of the Ranibizumab Port Delivery System for Sustained Delivery of Ranibizumab in Patients With Subfoveal Neovascular Age-Related Macular Degeneration | September 28, 2015 | March 28, 2019 |
| NCT02540954 | Completed | Phase 3 | Efficacy and Safety of Two Different Aflibercept Regimens in Subjects With Neovascular Age-related Macular Degeneration (nAMD) | September 29, 2015 | June 4, 2020 |
| NCT02543229 | Completed | Phase 1 | Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD | July 2015 | September 2017 |
| NCT02555995 | Completed | N/A | Assessment of Scan Quality of Sparse OCT Retina Scanner (MimoStudy01) | November 2015 | January 2016 |
| NCT02558712 | Completed | N/A | Technology-based Eye Care Services (TECS) Compare | March 2016 | September 23, 2017 |
| NCT02569892 | Completed | N/A | Non-Damaging Photothermal Therapy of Non-exudative Age Related Macular Degeneration | September 1, 2016 | January 25, 2021 |
| NCT02581891 | Completed | Phase 4 | Managing Neovascular (Known as "Wet") Age-related Macular Degeneration Over 2 Years Using Different Treatment Schedules of 2 mg Intravitreal Aflibercept Injected in the Eye | November 19, 2015 | April 26, 2019 |
| NCT02615496 | Completed | Evaluation of Physician and Patient Knowledge of Safety and Safe Use Information for Aflibercept | December 7, 2015 | January 31, 2017 | |
| NCT02659098 | Completed | Phase 2 | A Study to Evaluate the Safety and Clinical Response of Subretinal Administration of CNTO 2476 in Participants With Geographic Atrophy | December 4, 2015 | June 5, 2019 |
| NCT02686658 | Completed | Phase 2/Phase 3 | Zimura in Participants With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration | January 20, 2016 | April 23, 2020 |
| NCT02689518 | Completed | Phase 4 | EAGLE: Evaluating Genotypes Using Intravitreal Aflibercept Injection | April 2014 | November 12, 2019 |
| NCT02806830 | Completed | N/A | Ocular Discomfort Assessment After Intravitreal Injections | April 2016 | July 1, 2017 |
| NCT02821247 | Completed | Prospective Observational Study to Assess Effectiveness of Intravitreal Aflibercept in Patients With Wet Macular Degeneration in Greece | July 1, 2016 | December 13, 2019 | |
| NCT02859766 | Completed | Phase 1 | Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Patients With Neovascular AMD | December 7, 2016 | October 20, 2017 |
| NCT03318549 | Completed | N/A | BCI and Evaluation of Visual and Task Performance in Subjects With Eye Diseases | October 29, 2018 | May 31, 2023 |
| NCT03335852 | Completed | Phase 1 | Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Japanese Patients With Neovascular AMD | November 28, 2017 | October 8, 2018 |
| NCT03411941 | Completed | Evaluate the Effectiveness of Intravitreal (IVT) Aflibercept Injection in Clinical Practice in naïve Patients With Neovascular Age-related Macular Degeneration (nAMD) | February 28, 2018 | March 1, 2019 | |
| NCT03438669 | Completed | Correlation Between Visual Acuity Measurements, Quality of Life and Morphological Parameters in Wet AMD Patients | February 24, 2017 | October 27, 2017 | |
| NCT03470103 | Completed | A Study in Patients With Wet Age-related Macular Degeneration or Diabetic Macular Edema to Assess the freQuency of Use of Intravitreal Aflibercept in Routine Clinical Practices in Latin America | March 28, 2018 | January 15, 2021 | |
| NCT03521895 | Completed | An Integrated Analysis of the Effectiveness of Intravitreal (IVT) Aflibercept (Eylea) in Routine Clinical Practice Based on Two Large Observational Studies | May 1, 2018 | November 30, 2018 | |
| NCT03539549 | Completed | Phase 2 | A Study to Evaluate Abicipar Pegol for Safety and Treatment Effect in Participants With Neovascular Age-related Macular Degeneration (AMD) | May 25, 2018 | February 27, 2019 |
| NCT03714308 | Completed | Aflibercept Injection Into the Vitreous Body of the Eye: Study to Learn More About Patient Relevant Outcomes, Real World Treatment Patterns and How Well the Treatment Works for Patients Suffering From Abnormal Growth of New Blood Vessels Under the Retina. | January 28, 2019 | May 12, 2023 | |
| NCT03732287 | Completed | Phase 1/Phase 2 | Cooling Anesthesia for Intravitreal Injection | November 30, 2018 | April 26, 2019 |
| NCT03804099 | Completed | Phase 4 | Effect Aflibercept on Ocular Perfusion | March 1, 2017 | May 18, 2018 |
| NCT03805100 | Completed | Phase 3 | Comparing the Efficacy and Safety of Biosimilar Candidate Xlucane Versus Lucentis® in Patients With nAMD | April 19, 2019 | November 11, 2021 |
| NCT03946085 | Completed | N/A | Evaluation of a New Eye-specific Multivitamin Formula in Participants at Risk of Age-related Macular Degeneration (AMD) | January 19, 2018 | November 1, 2018 |
| NCT03954626 | Completed | Phase 3 | Study to Collect Safety and ECG Data on Brolucizumab 6 mg Intravitreal Treatment in Patients With Wet AMD | June 7, 2019 | July 31, 2019 |
| NCT03956797 | Completed | N/A | Long Term Safety of Cooling Anesthesia for Intravitreal Injection | April 15, 2019 | April 2, 2021 |
| NCT04111068 | Completed | N/A | Improving Vision in Adults With Macular Degeneration | December 1, 2019 | March 1, 2022 |
| NCT04141891 | Completed | N/A | Advancing Understanding of Transportation Options | December 12, 2019 | December 21, 2023 |
| NCT04246866 | Completed | Phase 1 | First in Human Study to Evaluate the Safety and Tolerability of GEM103 in Geographic Atrophy Secondary to Dry Age Related Macular Degeneration | December 19, 2019 | October 21, 2020 |
| NCT04435366 | Completed | Phase 3 | A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) | June 22, 2020 | August 22, 2023 |
| NCT04499703 | Completed | Evaluation of the Retinal Health Monitoring System Thickness Module | November 11, 2020 | January 25, 2021 | |
| NCT04741763 | Completed | N/A | "Night Vision and Carotenoids" | February 13, 2018 | August 20, 2020 |
| NCT04988178 | Completed | Analysis of naïve Patients With Age-related Macular Degeneration Neovascular Type and Treated With Ranibizumab (Lucentis®) in Treat-and-extend at the CHU Brugmann. | April 13, 2021 | September 22, 2021 | |
| NCT05100511 | Completed | N/A | Fundus Image-guided Focal Electroretinography, Usability Study | November 4, 2021 | August 25, 2022 |
| NCT05904444 | Completed | N/A | The Effect of Duration Between Sessions on Microperimetric Biofeedback Training in Patients With Maculopathies | August 15, 2018 | April 30, 2023 |
| NCT00058994 | Completed | Phase 3 | An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMD | March 2003 | November 2006 |
| NCT00060749 | Completed | Phase 1 | Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-like Macular Dystrophy | May 5, 2003 | December 10, 2007 |
| NCT00061594 | Completed | Phase 3 | A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration | May 2003 | September 2006 |
| NCT00071227 | Completed | Phase 1 | Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel Disorders | October 15, 2003 | August 15, 2007 |
| NCT00087763 | Completed | Phase 2 | Pegaptanib Sodium on Foveal Thickening in Patients With Exudative Subfoveal Age-Related Macular Degeneration (AMD) | March 2004 | May 2006 |
| NCT00088192 | Completed | N/A | Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD) | July 2004 | |
| NCT00090623 | Completed | Phase 3 | A Study of rhuFab V2 (Ranibizumab) in Subjects With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD) | August 2004 | March 2007 |
| NCT00095433 | Completed | Phase 3 | Extension Study of rhuFab V2 in Subjects With Neovascular Age-Related Macular Degeneration (AMD) | September 2002 | August 2006 |
| NCT00100009 | Completed | Phase 3 | Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular Degeneration | December 9, 2004 | December 20, 2006 |
| NCT00101764 | Completed | Phase 1 | Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders | January 5, 2005 | May 20, 2008 |
| NCT00109499 | Completed | Phase 1 | Study of AdGVPEDF.11D in Neovascular Age-related Macular Degeneration (AMD) | ||
| NCT00121407 | Completed | Phase 3 | Visudyne® in Occult (VIO) | March 2002 | August 2005 |
| NCT00121589 | Completed | Phase 1 | Lutein/Zeaxanthin and Omega-3 Supplementation in Persons Over Age 60 | July 14, 2005 | August 15, 2007 |
| NCT00150202 | Completed | Phase 3 | Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration) | July 2004 | October 2006 |
| NCT00211458 | Completed | Phase 2 | Treatment of Age-Related Macular Degeneration With Anecortave Acetate | September 2005 | September 2007 |
| NCT00220805 | Completed | Phase 2 | Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration | January 2004 | May 2005 |
| NCT00239928 | Completed | Phase 2 | Clinical Study Of Pegaptanib Sodium (EYE001) For Wet-Type Age-Related Macular Degeneration | September 2005 | November 2008 |
| NCT00242580 | Completed | Phase 3 | A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib | September 2005 | |
| NCT00259753 | Completed | Phase 2 | Safety and Efficacy Study of Small Interfering Ribonucleic Acid (RNA) Molecule (Cand5) to Treat Wet Age-Related Macular Degeneration | July 2005 | December 2007 |
| NCT00299507 | Completed | Phase 3 | Anecortave Acetate in Patients With Exudative Age-related Macular Degeneration (AMD) | March 2005 | April 2008 |
| NCT00308477 | Completed | Phase 1/Phase 2 | A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion | ||
| NCT00320775 | Completed | Phase 1 | Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD | June 2005 | August 2008 |
| NCT00320788 | Completed | Phase 2 | Safety and Efficacy of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Wet Age-Related Macular Degeneration (AMD) | April 2006 | August 2008 |
| NCT00324116 | Completed | Phase 4 | Evaluation Of Safety And Efficacy Of 0.3 Mg/Eye Macugen In Patients With Small Age-Related Macular Degeneration Lesions | July 2006 | August 2008 |
| NCT00343603 | Completed | Tracking Optical Coherence Tomography | October 2004 | January 2011 | |
| NCT00359164 | Completed | Phase 2 | Phase II Pilot Study of Visudyne® Photodynamic Therapy (PDT) (Low and Very Low Fluence) Combined With Bevacizumab. | July 2006 | August 2008 |
| NCT00385333 | Completed | Phase 2 | Metabolic Mapping to Measure Retinal Metabolism | September 29, 2006 | September 16, 2010 |
| NCT00395707 | Completed | Phase 1/Phase 2 | Study To Determine Safety/Efficacy of Lucentis For Treatment Of Retinal Angiomatous Proliferation Secondary To Age Related Macular Degeneration | August 2005 | April 2008 |
| NCT00000145 | Completed | Phase 3 | Age-Related Eye Disease Study (AREDS) | September 1990 | December 2006 |
| NCT00426998 | Completed | Phase 2 | Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD | April 2006 | |
| NCT00436553 | Completed | Phase 3 | Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization | February 2007 | October 2009 |
| NCT00447954 | Completed | Phase 2 | A Study of an Encapsulated Cell Technology (ECT) Implant for Patients With Atrophic Macular Degeneration | January 2007 | October 2009 |
| NCT00460408 | Completed | Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration | August 2006 | February 2012 | |
| NCT00463320 | Completed | Phase 1 | A Study To Evaluate The Safety, Tolerability And Pk Of Pazopanib Eye Drops In Healthy Adult And Elderly Subjects. | March 2007 | August 2007 |
| NCT00465400 | Completed | Oxidative Stress in Patients With Age-Related Macular Degeneration | November 2006 | December 2007 | |
| NCT00467935 | Completed | Phase 1/Phase 2 | Scotoma Reduction in AMD Patients Treated With Ranibizumab | March 2007 | November 2007 |
| NCT00469352 | Completed | Phase 3 | A Study of Genetic and Environmental Factors and Their Effect on Response to Treatment With Lucentis (Ranibizumab) for Wet AMD | May 2007 | April 2010 |
| NCT00478530 | Completed | N/A | The Effect of Intravitreal Avastin on the Retina Measured by Electroretinogram | May 2007 | October 2008 |
| NCT00492284 | Completed | Phase 2 | Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL) | July 2007 | May 2010 |
| NCT00509795 | Completed | Phase 3 | Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD) | August 2007 | July 2011 |
| NCT00523406 | Completed | Phase 3 | Comparison of Reduced Fluence Versus Standard Photodynamic Therapy (in Combination With Intravitreal Triamcinolone Acetate) | August 2005 | January 2008 |
| NCT00527423 | Completed | Phase 2 | Randomized, Single-Masked, Long-Term, Safety and Tolerability Study of VEGF Trap-Eye in AMD | August 2007 | October 2011 |
| NCT00527475 | Completed | Phase 2 | Ranibizumab and Reduced Fluence PDT for AMD | May 2007 | January 2010 |
| NCT00531024 | Completed | Phase 2/Phase 3 | Systemic Avastin Therapy in Age-Related Macular Degeneration | August 2005 | March 2008 |
| NCT00531141 | Completed | The Optical Coherence Tomography in Age-Related Macular Degeneration Study: The OCT in AMD Study | May 2007 | June 2008 | |
| NCT00531336 | Completed | Phase 2 | MAAM Study: Avastin and Macugen Versus Avastin Versus Macugen | July 2006 | December 2008 |
| NCT00533520 | Completed | Phase 4 | Evaluation of Dosing Interval of Higher Doses of Ranibizumab | September 2007 | November 2013 |
| NCT00536016 | Completed | Phase 1 | A Phase 1 Safety Study of Single and Repeated Doses of JSM6427 (Intravitreal Injection) to Treat AMD | September 2007 | December 2009 |
| NCT00559234 | Completed | Potential Research Participants for Future Studies of Inherited Eye Diseases | November 9, 2007 | October 3, 2008 | |
| NCT05566626 | Enrolling by invitation | N/A | Retinal Oxygenation Estimation Trial With Mantis Photonics Hyperspectral Camera | October 2022 | December 2023 |
| NCT00349739 | No longer available | Treatment of Patients With Age-Related Macular Degeneration With Anecortave Acetate | January 2003 | August 2008 | |
| NCT06198452 | Not yet recruiting | N/A | Vision Improvement for Patients With Age-Related Macular Degeneration | January 1, 2024 | June 30, 2026 |
| NCT04008121 | Not yet recruiting | Early Phase 1 | Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium | April 2024 | July 2024 |
| NCT06074731 | Recruiting | Diagnostic Possibilities in Ophthalmological Diseases Using Swept Source Optical Coherence Tomography | June 1, 2017 | December 2026 | |
| NCT06394232 | Recruiting | Phase 1/Phase 2 | Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration. | June 4, 2024 | December 2030 |
| NCT05283941 | Recruiting | N/A | Pistachios and Neural Macular Pigment | June 10, 2022 | November 30, 2023 |
| NCT05147701 | Recruiting | Phase 1 | Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Eye Diseases | February 1, 2022 | January 2026 |
| NCT06203106 | Recruiting | NYSCF Scientific Discovery Biobank | November 10, 2022 | November 10, 2045 | |
| NCT05839041 | Recruiting | Phase 2 | A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) | May 2, 2023 | June 2026 |
| NCT05130385 | Recruiting | High Resolution Optical Coherence Tomography | November 30, 2021 | November 30, 2023 | |
| NCT03011541 | Recruiting | N/A | Stem Cell Ophthalmology Treatment Study II | January 2016 | July 31, 2026 |
| NCT06305416 | Recruiting | Phase 3 | A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema | March 30, 2024 | April 2025 |
| NCT04658251 | Recruiting | Study of New Mutations in Cone Disorders | March 3, 2021 | March 2026 | |
| NCT05797896 | Recruiting | Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study | February 7, 2023 | December 31, 2026 | |
| NCT06262737 | Recruiting | Single-center Study Measuring OSDI Dry Eye Score in Patients Undergoing an Anti-VEGF Induction Protocol | September 30, 2023 | October 1, 2025 | |
| NCT05637255 | Recruiting | Phase 2 | A Randomized, Double Masked, Parallel Group, Dose-finding Study to Evaluate SYL1801 in Patients With Neovascular Age-related Macular Degeneration (AMD) | November 22, 2022 | November 22, 2023 |
| NCT06224751 | Recruiting | Developing Better Computerised Vision Tests (CVTV) | April 2024 | January 2025 | |
| NCT05456581 | Recruiting | N/A | Scotoma Perimetry Oculomotor Training | November 1, 2022 | April 2025 |
| NCT04567303 | Recruiting | Phase 1 | Study of Zifibancimig in Participants With Neovascular Age-Related Macular Degeneration | October 28, 2020 | December 29, 2027 |
| NCT05454124 | Recruiting | N/A | Factors in Learning And Plasticity: Macular Degeneration | November 1, 2022 | November 2025 |
| NCT04762368 | Recruiting | N/A | Learning Study: Improving Vision in Adults With Macular Degeneration | February 13, 2021 | December 2024 |
| NCT03614481 | Recruiting | Clinical and Genetic Analyzes of Age-related Macular Degeneration | November 2005 | November 2024 | |
| NCT05445063 | Recruiting | Phase 1 | Safety and Efficacy of Autologous Transplantation of iPSC-RPE in the Treatment of Macular Degeneration | August 2022 | December 2026 |
| NCT05439759 | Recruiting | N/A | Factors in Learning And Plasticity: Healthy Vision | October 24, 2022 | November 2025 |
| NCT00509548 | Terminated | Phase 2 | Open-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMD | July 2007 | March 2008 |
| NCT00065728 | Terminated | Phase 3 | Open-Label Posterior Juxtascleral Injections of Anecortave Acetate 15mg Dose for Long Term Use in Patients With AMD | June 2003 | October 2008 |
| NCT04643886 | Terminated | Phase 2 | A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Dry Age-related Macular Degeneration | July 30, 2020 | March 21, 2022 |
| NCT00089830 | Terminated | Phase 2 | A Safety and Efficacy Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration | August 2004 | May 2007 |
| NCT04684394 | Terminated | Phase 2 | A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Neovascular Age-related Macular Degeneration | December 29, 2020 | February 18, 2022 |
| NCT00094120 | Terminated | Phase 2 | MSI-1256F (Squalamine Lactate) in Combination With Verteporfin in Patients With "Wet" Age-Related Macular Degeneration (AMD) | October 2004 | February 2007 |
| NCT01021956 | Terminated | Phase 2 | Safety and Preliminary Efficacy Study of WST11 (Stakel®)-Mediated VTP Therapy in Subjects With CNV Associated With AMD | June 2010 | January 2014 |
| NCT04685824 | Terminated | N/A | Visual Telerehabilitation in AMD Patients | September 15, 2021 | October 6, 2023 |
| NCT01025232 | Terminated | Phase 1/Phase 2 | A Study of Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial) | December 2009 | January 2013 |
| NCT00102115 | Terminated | Phase 1 | Study of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related Macular Disease | December 2004 | January 2006 |
| NCT01189019 | Terminated | Phase 2 | HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration | August 2010 | March 2013 |
| NCT00312351 | Terminated | Phase 4 | A Clinical Trial to Explore the Safety and Efficacy of Three Different Doses of Pegaptanib Sodium in Patients With Wet Age-Related Macular Degeneration (AMD) | April 2006 | November 2006 |
| NCT01362348 | Terminated | Phase 2 | 12 Week Patient Study in Neovascular Age-related Macular Degeneration (AMD) | July 7, 2011 | April 16, 2012 |
| NCT00327470 | Terminated | Phase 4 | An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD | July 2006 | August 2009 |
| NCT00333476 | Terminated | Phase 2 | A Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration | May 2006 | |
| NCT03105609 | Terminated | Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging | November 14, 2017 | December 1, 2018 | |
| NCT03133117 | Terminated | N/A | Deficits, Adaptation and Cerebral Functional Reorganization of Visual Retinotopic Treatments During Normal and Pathological Aging (Age-related Macular Degeneration and Glaucoma) | February 2, 2017 | May 25, 2018 |
| NCT00403442 | Terminated | Phase 1 | Bevacizumab in Combination With Verteporfin Reduced and Standard Fluence in the Treatment of Hemorrhaged Lesions in Neovascular AMD | September 2006 | |
| NCT00414206 | Terminated | Phase 2 | Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD) | March 2007 | September 2009 |
| NCT00433017 | Terminated | Phase 2/Phase 3 | Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD) | May 2007 | July 2009 |
| NCT01746875 | Terminated | N/A | A Study Testing if Medicine Can Make Pigment Epithelium Detachments Regress and Stabilize the Vision in Eyes | February 2014 | September 2015 |
| NCT00444249 | Terminated | N/A | Influence of Blue Light Filtering Intraocular Lenses on Daytime Levels of Melatonin | March 2007 | August 2008 |
| NCT00499590 | Terminated | Phase 3 | Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD | August 2007 | May 2009 |
| NCT00058695 | Terminated | Genetic Factors in Age-Related Macular Degeneration | April 4, 2003 | October 21, 2015 | |
| NCT02032173 | Terminated | Phase 3 | Efficacy and Safety of Lucentis® Use in Patients With Diabetic Macular Edema Evaluating a Spaced Out Follow-up After Intensive Treatment Phase | May 19, 2014 | April 29, 2015 |
| NCT02087085 | Terminated | Phase 2 | A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration | May 9, 2014 | March 30, 2018 |
| NCT05571267 | Terminated | Phase 2 | Safety Study of Zimura™in Combination With Anti-VEGF Therapy in Patients With Neovascular AMD | October 20, 2016 | April 24, 2018 |
| NCT02222207 | Terminated | Phase 2 | Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration | October 2014 | June 2015 |
| NCT02228304 | Terminated | Phase 1/Phase 2 | Study of the Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology (ECT) for the Treatment of Recurrent Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD) | September 2014 | April 2016 |
| NCT00619229 | Terminated | Phase 3 | Alprostadil in Maculopathy Study (AIMS) | July 2006 | February 2010 |
| NCT02348359 | Terminated | Phase 2 | X-82 to Treat Age-related Macular Degeneration | March 16, 2015 | January 12, 2018 |
| NCT04002310 | Terminated | Phase 1 | A Study to Test How Well Different Doses of BI 754132 Are Tolerated in Patients With an Advanced Form of Age-related Macular Degeneration Called Geographic Atrophy | July 26, 2019 | August 9, 2022 |
| NCT00709657 | Terminated | N/A | The Effect of a Single Intravitreal Anti-VEGF Therapy on Optic Nerve Head Perfusion | March 2008 | November 2011 |
| NCT00735943 | Terminated | Macugen Observational Study | November 2008 | August 2010 | |
| NCT04640649 | Unknown status | N/A | Prediction of Progression of Age-Related Macular Degeneration | November 2020 | December 2021 |
| NCT00100087 | Unknown status | Phase 1/Phase 2 | Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System | October 2004 | |
| NCT01920867 | Unknown status | N/A | Stem Cell Ophthalmology Treatment Study | August 2012 | July 2020 |
| NCT01213667 | Unknown status | Phase 4 | Genetics in Non-response to Anti-VEGF Treatment in Exudative AMD | January 2010 | December 2017 |
| NCT03725566 | Unknown status | N/A | JY028 Single Vitreous Injection in a Phase 1 Clinical Trial in nAMD Patients | May 22, 2018 | May 1, 2020 |
| NCT00078221 | Unknown status | Phase 3 | Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD) | August 1999 | December 2005 |
| NCT02067013 | Unknown status | Phase 2 | Analysis of Aqueous and Vitreous Humor | July 2015 | July 2017 |
| NCT02486484 | Unknown status | Phase 2 | Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection | March 2015 | December 2019 |
| NCT02827071 | Unknown status | Ocular Imaging Study Using Advanced OCT | July 2016 | ||
| NCT00157976 | Unknown status | Phase 3 | Double-Masked Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Age-Related Macular Degeneration | September 2005 | |
| NCT02747368 | Unknown status | N/A | Evaluation of Visual Function and Driving Health Using Ocusweep in Patients Suffering From Wet Age-related Macular Degeneration | April 2016 | April 2021 |
| NCT00380172 | Unknown status | N/A | Long-Term Efficacy in AMD of Rheopheresis in North America | October 2005 | October 2007 |
| NCT00454389 | Unknown status | Phase 3 | A Study of Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration | April 2007 | August 2012 |
| NCT01521065 | Unknown status | Phase 2 | An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration | September 2012 | October 2016 |
| NCT02941406 | Unknown status | MP3 (Microperimeter 3) Reproducibility in Healthy Subjects and Macular Patients | July 2015 | December 2016 | |
| NCT00466076 | Unknown status | Phase 2/Phase 3 | Copaxone in Age Related Macular Degeneration | August 2006 | April 2007 |
| NCT02868424 | Unknown status | Early Phase 1 | Treatment of Age-related Macular Degeneration by Fetal Retinal Pigment Epithelial Cells Transplantation | February 13, 2016 | December 2018 |
| NCT01217762 | Unknown status | Phase 1 | Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) | July 2008 | October 2014 |
| NCT00032396 | Unknown status | Phase 2 | A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration | November 2001 | |
| NCT00745511 | Unknown status | Phase 1/Phase 2 | Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD) | March 2009 | June 2010 |
| NCT00000161 | Unknown status | Phase 3 | Randomized Trials of Vitamin Supplements and Eye Disease | August 1993 | |
| NCT00996684 | Unknown status | Phase 2 | Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration | October 2009 | December 2011 |
| NCT00000152 | Unknown status | Phase 3 | Randomized Trial of Beta-Carotene and Macular Degeneration | April 1982 | |
| NCT00000158 | Unknown status | Phase 3 | Macular Photocoagulation Study (MPS) | February 1979 | |
| NCT04714424 | Unknown status | Comparing Vision Tests in a Virtual Reality Headset to Existing Analogues | November 13, 2019 | July 2023 | |
| NCT02749734 | Unknown status | Phase 1/Phase 2 | Clinical Study of Subretinal Transplantation of Human Embryo Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Macular Degeneration Diseases | May 2015 | December 2019 |
| NCT00684853 | Unknown status | Phase 2 | Intravitreal Bevacizumab Combined With PDT Versus Bevacizumab to Treat Exudative AMD | November 2007 | |
| NCT01655589 | Unknown status | VEGF Gene Association With Response to Neovascular Age-related Macular Degeneration With Anti-VEGF Agents | January 2008 | ||
| NCT00695682 | Unknown status | Phase 1 | Intravitreal Infliximab for Diabetic Macular Edema (DME) and Choroidal Neovascularization (CNV) | June 2008 | December 2008 |
| NCT00813891 | Unknown status | Phase 4 | Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration | January 2009 | December 2009 |
| NCT00926913 | Withdrawn | Investigating Optical and Neural Causes of Vision Loss | December 2014 | July 2015 | |
| NCT00538538 | Withdrawn | Phase 1 | Subretinal Lucentis for Hemorrhagic Age-related Macular Degeneration (AMD) | September 2007 | October 2008 |
| NCT01339949 | Withdrawn | N/A | Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients With Recurrent Leakage Secondary to Choroidal Neovascularisation (CNV) | June 2011 | October 2014 |
| NCT05675917 | Withdrawn | N/A | MacuTest Website for Personalized AMD Risk Prediction and Prevention | February 2, 2024 | February 2, 2024 |
| NCT04428242 | Withdrawn | Study Evaluating Retinal Health Monitoring System Thickness Module | April 2020 | July 2020 | |
| NCT02895815 | Withdrawn | Phase 2 | Efficacy and Safety Study of CNTO 2476 in Participants With Visual Acuity Impairment Associated With Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD) | April 9, 2018 | August 19, 2022 |
| NCT03603990 | Withdrawn | N/A | Effect of Vitrectomy on the Evolution of Refractory Diabetic Macular Edema | September 1, 2018 | March 1, 2020 |
| NCT00447031 | Withdrawn | N/A | Combination Therapy for Neovascular Age Related Macular Degeneration | March 2007 | November 2007 |
- Disase is a (Disease Ontology)
- DOID:8466
- Cross Reference ID (Disease Ontology)
- MESH:D008268
- Cross Reference ID (Disease Ontology)
- NCI:C123330
- Cross Reference ID (Disease Ontology)
- ORDO:279
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:302891003
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0024437
- Exact Synonym (Disease Ontology)
- Macular degeneration of retina
- HPO alt_id (Human Phenotype Ontology)
- HP:0007694
- HPO alt_id (Human Phenotype Ontology)
- HP:0007868
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0000608
- MeSH unique ID (MeSH (Medical Subject Headings))
- D008268